Y-mAbs Therapeutics
YMAB
#8047
Rank
ยฃ0.15 B
Marketcap
ยฃ3.52
Share price
-2.58%
Change (1 day)
-69.45%
Change (1 year)

Revenue for Y-mAbs Therapeutics (YMAB)

Revenue in 2024 (TTM): ยฃ68.71 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ67.97 Million. an increase over the revenue in the year 2023 that were of ยฃ66.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Y-mAbs Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ69.87 M4.95%
2023 ยฃ66.57 M23.41%
2022 ยฃ53.94 M108.68%
2021 ยฃ25.85 M69.83%
2020 ยฃ15.22 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA